Overview
Lobular carcinoma in situ with microinvasion (LCIS-MI) represents a precancerous condition characterized by atypical cells confined within lobules of the breast tissue, with minimal invasion into surrounding stroma. This condition is clinically significant as it identifies individuals at a higher risk for developing invasive breast cancer, particularly invasive lobular carcinoma. LCIS-MI predominantly affects women, though rare cases in men have been reported. Early detection and management are crucial as they can influence the trajectory of disease progression and reduce the risk of subsequent malignancies. Understanding LCIS-MI is vital in day-to-day practice for guiding surveillance strategies and preventive measures in high-risk patients 6.Pathophysiology
The pathophysiology of LCIS-MI involves complex molecular and cellular alterations that initiate within the lobular epithelium. Initially, genetic mutations, often involving genes like TP53 and CDH1, disrupt normal cell cycle regulation and epithelial integrity 6. These mutations lead to the accumulation of atypical cells that exhibit loss of polarity and cohesion, hallmarks of lobular neoplasia. The microinvasion component suggests that some cells have breached the basement membrane, albeit minimally, indicating a transitional phase towards invasive disease. This transition is facilitated by aberrant signaling pathways, including those mediated by growth factors and hormones, which promote proliferation and survival of these atypical cells 6. Over time, these cellular changes can progress if not intercepted, potentially leading to full-blown invasive carcinoma.Epidemiology
The exact incidence and prevalence of LCIS-MI are not extensively detailed in the provided sources, which focus more on environmental contaminants rather than breast pathology. However, LCIS without microinvasion is known to occur in approximately 0.5% to 1% of benign breast biopsies 6. Age distribution typically spans middle-aged women, with no significant sex disparity noted beyond the general predominance in females. Risk factors include a family history of breast cancer, personal history of atypical hyperplasia, and certain genetic syndromes like BRCA1 mutations. Trends suggest an increasing awareness and detection rate due to advancements in imaging and biopsy techniques, though direct epidemiological data specific to LCIS-MI are limited 6.Clinical Presentation
Patients with LCIS-MI often present with subtle clinical findings, making it challenging to diagnose based on symptoms alone. Commonly, the condition is discovered incidentally during mammography or ultrasound evaluations for other breast concerns. Typical presentations include a palpable, often well-demarcated, non-tender mass that may be multifocal or bilateral. Imaging features frequently show clustered microcalcifications or architectural distortions without significant associated masses 6. Red-flag features include rapid growth of a lesion, skin changes indicative of advanced disease, or symptoms suggestive of systemic involvement, prompting urgent referral for further evaluation 6.Diagnosis
The diagnosis of LCIS-MI involves a combination of imaging studies and histopathological examination. Initial imaging modalities such as mammography and ultrasound can suggest suspicious areas requiring biopsy. Core needle biopsy or excisional biopsy is definitive, revealing the characteristic lobular architecture with atypical cells and minimal stromal invasion 6. Specific diagnostic criteria include:Management
Initial Management
Second-Line Management
Specialist Escalation
Complications
Prognosis & Follow-Up
The prognosis for patients with LCIS-MI is generally guarded due to the increased risk of developing invasive breast cancer. Prognostic indicators include the extent of atypia, presence of genetic mutations, and family history. Recommended follow-up intervals typically involve clinical exams every 6-12 months, with imaging (mammography and possibly MRI) tailored to individual risk profiles. Regular reassessment helps in early detection of any changes that might necessitate more aggressive management 6.Special Populations
Key Recommendations
References
1 Wan C, Liu Y, Xie J, Chen F, Shen H, Li R. Evaluation of near infrared spectroscopy for direct detection of common microplastics contamination in camel Milk powder. Food chemistry 2026. link 2 Ribeiro VV, Castro ÍB. Barnacles as emerging sentinels of microplastic contamination: A global synthesis and analytical framing. Marine pollution bulletin 2026. link 3 Ribeiro VV, Sanz-Lazaro C, Yáñez ÁC, Soares TMA, do Prado CCA, Castro ÍB. Oyster as sentinels of recent microplastic contamination: Insights from a transplant experiment. Marine pollution bulletin 2026. link 4 Sayadi MH, Nowrouzi M, Eslami N, Emami S, Mehdinia A. Evaluating the effectiveness of adsorption nano-techniques for microplastic removal: Insights and future prospects. Marine pollution bulletin 2026. link 5 Jiao M, Zhu L, Jiang C, Wei N, Sun Y, Wang J et al.. Application and Validation of the First Automatic Pretreatment Unit for Aquatic Microplastics. Environmental science & technology 2026. link 6 Jeong Y, Jang EH, Kim G, Lee K, Jang J, Chung S. Surface-engineered anisotropic Fe3O4 nanoplates for highly efficient magnetic field-assisted micro/nanoplastics remediation. Journal of environmental management 2026. link 7 Sujathan S, El-Zein A. Performance of analytical techniques for microplastic and nanoplastic quantification in the presence of clay. Water research 2026. link 8 Shi Y, Liang L, Meng L, Hou J. Niche vs. habitat: Insights of aging microplastics and wetland types on bacterial community assembly. Journal of environmental sciences (China) 2026. link